Buteyko Method for Asthmatic Children With Mouth Breathing

THE EFFECTS OF THE BUTEYKO METHOD IN MOUTH BREATHING ASTHMATIC CHILDREN: A CONTROLLED RANDOMIZED STUDY

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02724657

Enrollment

Registered

2016-03-31

Start date

2016-03-31

Completion date

2016-10-31

Last updated

2017-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Mouth Breathing

Keywords

Child, Breathing exercises

Brief summary

To assess the effectiveness of the Buteyko method as an adjunct therapy in the treatment of asthmatic children with mouth breathing.

Interventions

OTHERButeyko Method

Intervention will be held twice a week during 3 weeks.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

7 Years to 12 Years

Healthy volunteers

Inclusion criteria

* Children from 7 up to 12 years old with asthma diagnose * Regular inhaled corticosteroids with no change in dose in the preceding 4 weeks. * Children cannot present: other respiratory disease (such as cystic fibrosis, bronchiectasis, and tuberculosis), retinal detachment, hypertensive crisis, congenital heart defect, pulmonary edema, history of lobectomy or lung segmentectomy, respiratory infections 15 days prior to the evaluations.

Exclusion criteria

* Children that are not able to perform some of the necessary procedures, give up participating in the research and present acute symptoms of respiratory tract during the assessments.

Design outcomes

Primary

Measure	Time frame	Description
Change in Sleep disturbance (questionnaire)	Baseline, three weeks later and six months after treatment	Sleep disturbance will be assessed by the sleep disturbance scale for children (SDSC).

Secondary

Measure	Time frame	Description
Change in spirometry (FVC, FEV1, FEV1/FVC, FEF25-75%, PEF)	Baseline, three weeks later and six months after treatment	—
Change in ventilometry (minute volume and vital capacity)	Baseline, three weeks later and six months after treatment	Minute volume and vital capacity (liters)
Number of hospitalizations	Through study completion, an average of three weeks and six months after treatment	—
Number of days off-school	During the three weeks of treatment	—

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026